Future perspectives in melanoma research. Meeting report from the "Melanoma research: a bridge from Naples to the World. Napoli, December 5th-6th 2011"
- PMID: 22551296
- PMCID: PMC3390271
- DOI: 10.1186/1479-5876-10-83
Future perspectives in melanoma research. Meeting report from the "Melanoma research: a bridge from Naples to the World. Napoli, December 5th-6th 2011"
Abstract
After more than 30 years, landmark progress has been made in the treatment of cancer, and melanoma in particular, with the success of new molecules such as ipilimumab, vemurafenib and active specific immunization.After the first congress in December 2010, the second edition of "Melanoma Research: a bridge from Naples to the World" meeting, organized by Paolo A. Ascierto (INT, Naples, Italy), Francesco M. Marincola (NIH, Bethesda, USA), and Nicola Mozzillo (INT, Naples, Italy) took place in Naples, on 5-6 December 2011. We have identified four new topics of discussion: Innovative Approaches in Prevention, Diagnosis and Surgical Treatment, New Pathways and Targets in Melanoma: An Update about Immunotherapy, and Combination Strategies. This international congress gathered more than 30 international faculty members and was focused on recent advances in melanoma molecular biology, immunology and therapy, and created an interactive atmosphere which stimulated discussion of new approaches and strategies in the field of melanoma.
Figures
Similar articles
-
Future perspectives in melanoma research. Meeting report from the "Melanoma Research: a bridge Naples-USA. Naples, December 6th-7th 2010".J Transl Med. 2011 Mar 26;9:32. doi: 10.1186/1479-5876-9-32. J Transl Med. 2011. PMID: 21439082 Free PMC article.
-
Future perspectives in melanoma research. Meeting report from the "Melanoma Bridge. Napoli, December 2nd-4th 2012".J Transl Med. 2013 Jun 3;11:137. doi: 10.1186/1479-5876-11-137. J Transl Med. 2013. PMID: 23731854 Free PMC article.
-
Future perspectives in melanoma research : Meeting report from the "Melanoma Bridge". Napoli, December 1st-4th 2015.J Transl Med. 2016 Nov 15;14(1):313. doi: 10.1186/s12967-016-1070-y. J Transl Med. 2016. PMID: 27846884 Free PMC article.
-
Adjuvant immunotherapy for melanoma.J Surg Oncol. 2021 Mar;123(3):789-797. doi: 10.1002/jso.26329. J Surg Oncol. 2021. PMID: 33595889 Review.
-
Adjuvant therapy for cutaneous melanoma.Semin Oncol. 1995 Dec;22(6):647-61. Semin Oncol. 1995. PMID: 8539640 Review. No abstract available.
Cited by
-
Combination therapies in advanced melanoma.Melanoma Manag. 2014 Aug;1(1):47-56. doi: 10.2217/mmt.13.1. Epub 2014 Sep 5. Melanoma Manag. 2014. PMID: 30190810 Free PMC article. Review.
-
Molecular changes induced by the curcumin analogue D6 in human melanoma cells.Mol Cancer. 2013 May 4;12:37. doi: 10.1186/1476-4598-12-37. Mol Cancer. 2013. PMID: 23642048 Free PMC article.
-
The MAPK (ERK) Pathway: Investigational Combinations for the Treatment Of BRAF-Mutated Metastatic Melanoma.P T. 2013 Feb;38(2):96-108. P T. 2013. PMID: 23599677 Free PMC article.
-
Holistic view of patients with melanoma of the skin: how can health systems create value and achieve better clinical outcomes?Ecancermedicalscience. 2019 Aug 27;13:959. doi: 10.3332/ecancer.2019.959. eCollection 2019. Ecancermedicalscience. 2019. PMID: 31645887 Free PMC article. Review.
-
Vemurafenib and concomitant stereotactic radiation for the treatment of melanoma with spinal metastases: A case report.Rep Pract Oncol Radiother. 2016 Jan-Feb;21(1):76-80. doi: 10.1016/j.rpor.2015.07.005. Epub 2015 Sep 29. Rep Pract Oncol Radiother. 2016. PMID: 26900362 Free PMC article.
References
-
- Balch CM, Gershenwald JE, Soong SJ, Thompson JF, Atkins MB, Byrd DR, Buzaid AC, Cochran AJ, Coit DG, Ding S, Eggermont AM, Flaherty KT, Gimotty P, Kirkwood JM, McMasters KM, Mihm MC, Morton DL, Ross MI, Sober AJ, Sondak VK. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol. 2009;27:6199–6206. doi: 10.1200/JCO.2009.23.4799. - DOI - PMC - PubMed
-
- Balch CM, Gershenwald JE, Soong SJ, Thompson JF, Ding S, Byrd David R, Cascinelli N, Cochran AJ, Coit DG, Eggermont AM, Johnson T, Kirkwood JM, Leong SP, McMasters KM, Mihm MC, Morton DL, Ross MI, Sondak VK. Multivariate analysis of prognostic factors among 2,313 patients with stage III melanoma: comparison of nodal micrometastases versus macrometastases. J Clin Oncol. 2010;28:2452–2459. doi: 10.1200/JCO.2009.27.1627. - DOI - PMC - PubMed
-
- Balch CM, Gershenwald JE, Soong SJ, Thompson JF, Atkins MB, In: AJCC Cancer Staging Manual (ed 7th) Edge SE, Byrd DR, Carducci MA, editor. Springer, New York; 2009. Melanoma of the skin.
-
- Thompson JF, Soong SJ, Balch CM, Gershenwald JE, Ding S, Coit DG, Flaherty KT, Gimotty PA, Johnson T, Johnson MM, Leong SP, Ross MI, Byrd DR, Cascinelli N, Cochran AJ, Eggermont AM, McMasters KM, Mihm MC, Morton DL, Sondak VK. Prognostic significance of mitotic rate in localized primary cutaneous melanoma: an analysis of patients in the multi-institutional American Joint Committee on Cancer melanoma staging database. J Clin Oncol. 2011;29:2199–2205. doi: 10.1200/JCO.2010.31.5812. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical